NPM1 and acute myeloid leukemia: Among 140 patients with t-AML, they identified 10 patients harboring NPM1 mutations, of whom four had a normal karyotype and raised the question whether these four patients actually represented “de novo AML with medical history” rather that true t-AML [84,85].